LivaNova (LIVN) EBIT Growth (1y) (2015 - 2026)
LivaNova (LIVN) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 16.18% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -8.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.67% |
| Mar 31, 2026 | -14.70% |
| Dec 31, 2025 | 15.01% |
| Sep 30, 2025 | 51.64% |
| Jun 30, 2025 | 34.90% |
| Mar 31, 2025 | 199.26% |
| Dec 31, 2024 | 142.07% |
| Sep 30, 2024 | 698.97% |
| Jun 30, 2024 | 131.16% |
| Mar 31, 2024 | 793.68% |
| Dec 31, 2023 | -730.30% |
| Sep 30, 2023 | 103.38% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -124.64% |
| Dec 31, 2022 | -43.61% |
| Sep 30, 2022 | -903.64% |
| Jun 30, 2022 | 187.57% |
| Mar 31, 2022 | 266.81% |
| Dec 31, 2021 | 109.94% |
| Sep 30, 2021 | 317.45% |